198 related articles for article (PubMed ID: 23463740)
1. Alteplase for the treatment of catheter occlusion in pediatric patients.
Anderson DM; Pesaturo KA; Casavant J; Ramsey EZ
Ann Pharmacother; 2013 Mar; 47(3):405-9. PubMed ID: 23463740
[TBL] [Abstract][Full Text] [Related]
2. Alteplase for the treatment of central venous catheter occlusion in children: results of a prospective, open-label, single-arm study (The Cathflo Activase Pediatric Study).
Blaney M; Shen V; Kerner JA; Jacobs BR; Gray S; Armfield J; Semba CP;
J Vasc Interv Radiol; 2006 Nov; 17(11 Pt 1):1745-51. PubMed ID: 17142704
[TBL] [Abstract][Full Text] [Related]
3. Occluded Tunneled Venous Catheter in Hemodialysis Patients: Risk Factors and Efficacy of Alteplase.
Ponce D; Mendes M; Silva T; Oliveira R
Artif Organs; 2015 Sep; 39(9):741-7. PubMed ID: 25894244
[TBL] [Abstract][Full Text] [Related]
4. Effective use of alteplase for occluded tunneled venous catheter in hemodialysis patients.
Mendes ML; Castro JH; Silva TN; Barretti P; Ponce D
Artif Organs; 2014 May; 38(5):399-403. PubMed ID: 24117542
[TBL] [Abstract][Full Text] [Related]
5. Alteplase infusion versus dwell for clearance of partially occluded central venous catheters in critically ill pediatric patients.
Ragsdale CE; Oliver MR; Thompson AJ; Evans MC
Pediatr Crit Care Med; 2014 Jul; 15(6):e253-60. PubMed ID: 24751787
[TBL] [Abstract][Full Text] [Related]
6. Alteplase for blood flow restoration in hemodialysis catheters: a multicenter, randomized, prospective study comparing "dwell" versus "push" administration.
Vercaigne LM; Zacharias J; Bernstein KN
Clin Nephrol; 2012 Oct; 78(4):287-96. PubMed ID: 22541682
[TBL] [Abstract][Full Text] [Related]
7. Recombinant tissue plasminogen activator (alteplase) for restoration of function to occluded central venous catheters in pediatric patients.
Shen V; Li X; Murdock M; Resnansky L; McCluskey ER; Semba CP;
J Pediatr Hematol Oncol; 2003 Jan; 25(1):38-45. PubMed ID: 12544772
[TBL] [Abstract][Full Text] [Related]
8. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.
Ponec D; Irwin D; Haire WD; Hill PA; Li X; McCluskey ER;
J Vasc Interv Radiol; 2001 Aug; 12(8):951-5. PubMed ID: 11487675
[TBL] [Abstract][Full Text] [Related]
9. Alteplase versus urokinase for occluded hemodialysis catheters.
Zacharias JM; Weatherston CP; Spewak CR; Vercaigne LM
Ann Pharmacother; 2003 Jan; 37(1):27-33. PubMed ID: 12503929
[TBL] [Abstract][Full Text] [Related]
10. Alteplase use for malfunctioning central venous catheters correlates with catheter-associated bloodstream infections.
Rowan CM; Miller KE; Beardsley AL; Ahmed SS; Rojas LA; Hedlund TL; Speicher RH; Nitu ME
Pediatr Crit Care Med; 2013 Mar; 14(3):306-9. PubMed ID: 23392362
[TBL] [Abstract][Full Text] [Related]
11. Treatment of occluded central venous catheters with alteplase: results in 1,064 patients.
Semba CP; Deitcher SR; Li X; Resnansky L; Tu T; McCluskey ER;
J Vasc Interv Radiol; 2002 Dec; 13(12):1199-205. PubMed ID: 12471182
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study of the repeated use of alteplase as therapy for tunneled hemodialysis catheter dysfunction.
Little MA; Walshe JJ
Am J Kidney Dis; 2002 Jan; 39(1):86-91. PubMed ID: 11774106
[TBL] [Abstract][Full Text] [Related]
13. The use of alteplase to restore patency of central venous lines in pediatric patients: a cohort study.
Choi M; Massicotte MP; Marzinotto V; Chan AK; Holmes JL; Andrew M
J Pediatr; 2001 Jul; 139(1):152-6. PubMed ID: 11445811
[TBL] [Abstract][Full Text] [Related]
14. Alteplase vs. urokinase for occluded hemodialysis catheter: A randomized trial.
Pollo V; DionÃzio D; Bucuvic EM; Castro JH; Ponce D
Hemodial Int; 2016 Jul; 20(3):378-84. PubMed ID: 26851872
[TBL] [Abstract][Full Text] [Related]
15. Interventions for restoring patency of occluded central venous catheter lumens.
van Miert C; Hill R; Jones L
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD007119. PubMed ID: 22513946
[TBL] [Abstract][Full Text] [Related]
16. Safety, dose, and timing of reteplase in treating occluded central venous catheters in children with cancer.
Terrill KR; Lemons RS; Goldsby RE
J Pediatr Hematol Oncol; 2003 Nov; 25(11):864-7. PubMed ID: 14608195
[TBL] [Abstract][Full Text] [Related]
17. Use of tissue plasminogen activator for thrombolysis in occluded peritoneal dialysis catheters in children.
Shea M; Hmiel SP; Beck AM
Adv Perit Dial; 2001; 17():249-52. PubMed ID: 11510286
[TBL] [Abstract][Full Text] [Related]
18. Short and long alteplase dwells in dysfunctional hemodialysis catheters.
Macrae JM; Loh G; Djurdjev O; Shalansky S; Werb R; Levin A; Kiaii M
Hemodial Int; 2005 Apr; 9(2):189-95. PubMed ID: 16191068
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of reteplase for central venous catheter occlusion in patients with cancer.
Liu CY; Jain V; Shields AF; Heilbrun LK
J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):39-44. PubMed ID: 14709685
[TBL] [Abstract][Full Text] [Related]
20. Alteplase for treatment of occluded peripherally inserted central catheters: safety and efficacy in 240 patients.
Ng R; Li X; Tu T; Semba CP
J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):45-9. PubMed ID: 14709686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
